BCTG Holdings, LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-02 07:07 am Sale | 2024-12-30 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 10,740,385 10.000% | -4,473,668 (-29.40%) | Filing |
| 2023-10-18 5:23 pm Purchase | 2023-10-16 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 15,214,053 15.000% | 1,075,000 (+7.60%) | Filing |
| 2023-08-16 4:40 pm Purchase | 2023-08-11 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 14,139,053 13.900% | 7,150,603 (+102.32%) | Filing |
| 2022-01-04 5:03 pm Unchanged | 2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 6,988,450 8.000% | 0 (Unchanged) | Filing |
| 2021-08-20 4:31 pm Purchase | 2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX | BCTG Holdings, LLC | 6,988,450 8.300% | 6,988,450 (New Position) | Filing |